Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

February 01, 1986; Volume 29,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Ahlijanian, M K

    1. You have access
      Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.
      D M Cooper, C M Bier-Laning, M K Halford, M K Ahlijanian and N R Zahniser
      Molecular Pharmacology February 1986, 29 (2) 113-119;
  2. Antonello, C

    1. You have access
      A search for potential antitumor agents: biological effects and DNA binding of a series of anthraquinone derivatives.
      G Palù, M Palumbo, C Antonello, G A Meloni and S Marciani-Magno
      Molecular Pharmacology February 1986, 29 (2) 211-217;

B

  1. Baker, P F

    1. You have access
      Alpha 2-adrenoceptors do not regulate catecholamine secretion by bovine adrenal medullary cells: a study with clonidine.
      D A Powis and P F Baker
      Molecular Pharmacology February 1986, 29 (2) 134-141;
  2. Bier-Laning, C M

    1. You have access
      Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.
      D M Cooper, C M Bier-Laning, M K Halford, M K Ahlijanian and N R Zahniser
      Molecular Pharmacology February 1986, 29 (2) 113-119;
  3. Bigelow, J

    1. You have access
      Mechanism of binding of a benzomorphan opiate to the acetylcholine receptor from Torpedo electroplaque.
      R E Oswald, L Michel and J Bigelow
      Molecular Pharmacology February 1986, 29 (2) 179-187;
  4. Blackmore, P F

    1. You have access
      Effect of islet-activating pertussis toxin on the binding characteristics of Ca2+-mobilizing hormones and on agonist activation of phosphorylase in hepatocytes.
      C J Lynch, V Prpic, P F Blackmore and J H Exton
      Molecular Pharmacology February 1986, 29 (2) 196-203;
  5. Butt, T R

    1. You have access
      Regulation of metallothionein gene expression in mammalian cells by gold compounds.
      T R Butt, E J Sternberg, C K Mirabelli and S T Crooke
      Molecular Pharmacology February 1986, 29 (2) 204-210;

C

  1. Cantoni, O

    1. You have access
      Differences in the effects of Hg(II) on DNA repair induced in Chinese hamster ovary cells by ultraviolet or X-rays.
      N T Christie, O Cantoni, M Sugiyama, F Cattabeni and M Costa
      Molecular Pharmacology February 1986, 29 (2) 173-178;
  2. Cashman, J R

    1. You have access
      Contribution of N-oxygenation to the metabolism of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) by various liver preparations.
      J R Cashman and D M Ziegler
      Molecular Pharmacology February 1986, 29 (2) 163-167;
  3. Cattabeni, F

    1. You have access
      Differences in the effects of Hg(II) on DNA repair induced in Chinese hamster ovary cells by ultraviolet or X-rays.
      N T Christie, O Cantoni, M Sugiyama, F Cattabeni and M Costa
      Molecular Pharmacology February 1986, 29 (2) 173-178;
  4. Christie, N T

    1. You have access
      Differences in the effects of Hg(II) on DNA repair induced in Chinese hamster ovary cells by ultraviolet or X-rays.
      N T Christie, O Cantoni, M Sugiyama, F Cattabeni and M Costa
      Molecular Pharmacology February 1986, 29 (2) 173-178;
  5. Cooper, D M

    1. You have access
      Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.
      D M Cooper, C M Bier-Laning, M K Halford, M K Ahlijanian and N R Zahniser
      Molecular Pharmacology February 1986, 29 (2) 113-119;
  6. Costa, M

    1. You have access
      Differences in the effects of Hg(II) on DNA repair induced in Chinese hamster ovary cells by ultraviolet or X-rays.
      N T Christie, O Cantoni, M Sugiyama, F Cattabeni and M Costa
      Molecular Pharmacology February 1986, 29 (2) 173-178;
  7. Crooke, S T

    1. You have access
      Regulation of metallothionein gene expression in mammalian cells by gold compounds.
      T R Butt, E J Sternberg, C K Mirabelli and S T Crooke
      Molecular Pharmacology February 1986, 29 (2) 204-210;

D

  1. Daly, J W

    1. You have access
      A functionalized congener approach to adenosine receptor antagonists: amino acid conjugates of 1,3-dipropylxanthine.
      K A Jacobson, K L Kirk, W L Padgett and J W Daly
      Molecular Pharmacology February 1986, 29 (2) 126-133;

E

  1. Exton, J H

    1. You have access
      Effect of islet-activating pertussis toxin on the binding characteristics of Ca2+-mobilizing hormones and on agonist activation of phosphorylase in hepatocytes.
      C J Lynch, V Prpic, P F Blackmore and J H Exton
      Molecular Pharmacology February 1986, 29 (2) 196-203;

H

  1. Halford, M K

    1. You have access
      Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.
      D M Cooper, C M Bier-Laning, M K Halford, M K Ahlijanian and N R Zahniser
      Molecular Pharmacology February 1986, 29 (2) 113-119;
  2. Harden, T K

    1. You have access
      H1-histamine receptors on human astrocytoma cells.
      N Nakahata, M W Martin, A R Hughes, J R Hepler and T K Harden
      Molecular Pharmacology February 1986, 29 (2) 188-195;
  3. Hartig, P R

    1. You have access
      Solubilization and characterization of the serotonin 5-HT1c site from pig choroid plexus.
      K A Yagaloff and P R Hartig
      Molecular Pharmacology February 1986, 29 (2) 120-125;
  4. Heimbrook, D C

    1. You have access
      Biochemistry of misonidazole reduction by NADPH-cytochrome c (P-450) reductase.
      D C Heimbrook and A C Sartorelli
      Molecular Pharmacology February 1986, 29 (2) 168-172;
  5. Hepler, J R

    1. You have access
      H1-histamine receptors on human astrocytoma cells.
      N Nakahata, M W Martin, A R Hughes, J R Hepler and T K Harden
      Molecular Pharmacology February 1986, 29 (2) 188-195;
  6. Hinson, J A

    1. You have access
      Horseradish peroxidase-catalyzed oxidation of acetaminophen to intermediates that form polymers or conjugate with glutathione.
      D W Potter, D W Miller and J A Hinson
      Molecular Pharmacology February 1986, 29 (2) 155-162;
  7. Hughes, A R

    1. You have access
      H1-histamine receptors on human astrocytoma cells.
      N Nakahata, M W Martin, A R Hughes, J R Hepler and T K Harden
      Molecular Pharmacology February 1986, 29 (2) 188-195;

J

  1. Jacobson, K A

    1. You have access
      A functionalized congener approach to adenosine receptor antagonists: amino acid conjugates of 1,3-dipropylxanthine.
      K A Jacobson, K L Kirk, W L Padgett and J W Daly
      Molecular Pharmacology February 1986, 29 (2) 126-133;

K

  1. Kamaya, H

    1. You have access
      Anesthetic-protein interaction: surface potential of bovine serum albumin estimated by a pH-sensitive dye.
      T Mashimo, H Kamaya and I Ueda
      Molecular Pharmacology February 1986, 29 (2) 149-154;
  2. Kirk, K L

    1. You have access
      A functionalized congener approach to adenosine receptor antagonists: amino acid conjugates of 1,3-dipropylxanthine.
      K A Jacobson, K L Kirk, W L Padgett and J W Daly
      Molecular Pharmacology February 1986, 29 (2) 126-133;

L

  1. Lynch, C J

    1. You have access
      Effect of islet-activating pertussis toxin on the binding characteristics of Ca2+-mobilizing hormones and on agonist activation of phosphorylase in hepatocytes.
      C J Lynch, V Prpic, P F Blackmore and J H Exton
      Molecular Pharmacology February 1986, 29 (2) 196-203;

M

  1. Marciani-Magno, S

    1. You have access
      A search for potential antitumor agents: biological effects and DNA binding of a series of anthraquinone derivatives.
      G Palù, M Palumbo, C Antonello, G A Meloni and S Marciani-Magno
      Molecular Pharmacology February 1986, 29 (2) 211-217;
  2. Martin, M W

    1. You have access
      H1-histamine receptors on human astrocytoma cells.
      N Nakahata, M W Martin, A R Hughes, J R Hepler and T K Harden
      Molecular Pharmacology February 1986, 29 (2) 188-195;
  3. Mashimo, T

    1. You have access
      Anesthetic-protein interaction: surface potential of bovine serum albumin estimated by a pH-sensitive dye.
      T Mashimo, H Kamaya and I Ueda
      Molecular Pharmacology February 1986, 29 (2) 149-154;
  4. Meloni, G A

    1. You have access
      A search for potential antitumor agents: biological effects and DNA binding of a series of anthraquinone derivatives.
      G Palù, M Palumbo, C Antonello, G A Meloni and S Marciani-Magno
      Molecular Pharmacology February 1986, 29 (2) 211-217;
  5. Michel, L

    1. You have access
      Mechanism of binding of a benzomorphan opiate to the acetylcholine receptor from Torpedo electroplaque.
      R E Oswald, L Michel and J Bigelow
      Molecular Pharmacology February 1986, 29 (2) 179-187;
  6. Miller, D W

    1. You have access
      Horseradish peroxidase-catalyzed oxidation of acetaminophen to intermediates that form polymers or conjugate with glutathione.
      D W Potter, D W Miller and J A Hinson
      Molecular Pharmacology February 1986, 29 (2) 155-162;
  7. Mirabelli, C K

    1. You have access
      Regulation of metallothionein gene expression in mammalian cells by gold compounds.
      T R Butt, E J Sternberg, C K Mirabelli and S T Crooke
      Molecular Pharmacology February 1986, 29 (2) 204-210;

N

  1. Nakahata, N

    1. You have access
      H1-histamine receptors on human astrocytoma cells.
      N Nakahata, M W Martin, A R Hughes, J R Hepler and T K Harden
      Molecular Pharmacology February 1986, 29 (2) 188-195;

O

  1. Oswald, R E

    1. You have access
      Mechanism of binding of a benzomorphan opiate to the acetylcholine receptor from Torpedo electroplaque.
      R E Oswald, L Michel and J Bigelow
      Molecular Pharmacology February 1986, 29 (2) 179-187;

P

  1. Padgett, W L

    1. You have access
      A functionalized congener approach to adenosine receptor antagonists: amino acid conjugates of 1,3-dipropylxanthine.
      K A Jacobson, K L Kirk, W L Padgett and J W Daly
      Molecular Pharmacology February 1986, 29 (2) 126-133;
  2. Palù, G

    1. You have access
      A search for potential antitumor agents: biological effects and DNA binding of a series of anthraquinone derivatives.
      G Palù, M Palumbo, C Antonello, G A Meloni and S Marciani-Magno
      Molecular Pharmacology February 1986, 29 (2) 211-217;
  3. Palumbo, M

    1. You have access
      A search for potential antitumor agents: biological effects and DNA binding of a series of anthraquinone derivatives.
      G Palù, M Palumbo, C Antonello, G A Meloni and S Marciani-Magno
      Molecular Pharmacology February 1986, 29 (2) 211-217;
  4. Potter, D W

    1. You have access
      Horseradish peroxidase-catalyzed oxidation of acetaminophen to intermediates that form polymers or conjugate with glutathione.
      D W Potter, D W Miller and J A Hinson
      Molecular Pharmacology February 1986, 29 (2) 155-162;
  5. Powis, D A

    1. You have access
      Alpha 2-adrenoceptors do not regulate catecholamine secretion by bovine adrenal medullary cells: a study with clonidine.
      D A Powis and P F Baker
      Molecular Pharmacology February 1986, 29 (2) 134-141;
  6. Prpic, V

    1. You have access
      Effect of islet-activating pertussis toxin on the binding characteristics of Ca2+-mobilizing hormones and on agonist activation of phosphorylase in hepatocytes.
      C J Lynch, V Prpic, P F Blackmore and J H Exton
      Molecular Pharmacology February 1986, 29 (2) 196-203;

S

  1. Sartorelli, A C

    1. You have access
      Biochemistry of misonidazole reduction by NADPH-cytochrome c (P-450) reductase.
      D C Heimbrook and A C Sartorelli
      Molecular Pharmacology February 1986, 29 (2) 168-172;
  2. Snyder, S H

    1. You have access
      Characterization of angiotensin converting enzyme by [3H]captopril binding.
      S M Strittmatter and S H Snyder
      Molecular Pharmacology February 1986, 29 (2) 142-148;
  3. Sternberg, E J

    1. You have access
      Regulation of metallothionein gene expression in mammalian cells by gold compounds.
      T R Butt, E J Sternberg, C K Mirabelli and S T Crooke
      Molecular Pharmacology February 1986, 29 (2) 204-210;
  4. Strittmatter, S M

    1. You have access
      Characterization of angiotensin converting enzyme by [3H]captopril binding.
      S M Strittmatter and S H Snyder
      Molecular Pharmacology February 1986, 29 (2) 142-148;
  5. Sugiyama, M

    1. You have access
      Differences in the effects of Hg(II) on DNA repair induced in Chinese hamster ovary cells by ultraviolet or X-rays.
      N T Christie, O Cantoni, M Sugiyama, F Cattabeni and M Costa
      Molecular Pharmacology February 1986, 29 (2) 173-178;

U

  1. Ueda, I

    1. You have access
      Anesthetic-protein interaction: surface potential of bovine serum albumin estimated by a pH-sensitive dye.
      T Mashimo, H Kamaya and I Ueda
      Molecular Pharmacology February 1986, 29 (2) 149-154;

Y

  1. Yagaloff, K A

    1. You have access
      Solubilization and characterization of the serotonin 5-HT1c site from pig choroid plexus.
      K A Yagaloff and P R Hartig
      Molecular Pharmacology February 1986, 29 (2) 120-125;

Z

  1. Zahniser, N R

    1. You have access
      Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.
      D M Cooper, C M Bier-Laning, M K Halford, M K Ahlijanian and N R Zahniser
      Molecular Pharmacology February 1986, 29 (2) 113-119;
  2. Ziegler, D M

    1. You have access
      Contribution of N-oxygenation to the metabolism of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) by various liver preparations.
      J R Cashman and D M Ziegler
      Molecular Pharmacology February 1986, 29 (2) 163-167;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 29, Issue 2
1 Feb 1986
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Peptide Nanoformulations against the Tumor Microenvironment
  • Characterization of Vixotrigine
  • Dehydrocrenatidine Is a Novel JAK Inhibitor
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics